Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04385290
Title Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Technische Universität Dresden
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Gemtuzumab ozogamicin + Midostaurin

Cytarabine + Daunorubicin + Gemtuzumab ozogamicin

Age Groups: senior | adult
Covered Countries DEU

Additional content available in CKB BOOST